Clementia Pharmaceuticals Private Limited, a active private limited company, was established on 20 July 2012 in Thane, Maharashtra, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24290MH2012PTC233594. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.
It upholds a compliant status. Employing 19 professional, Its leadership includes Milind S Tawade (Director), Sudeepto Deepak Nag (Director), Ganesh Vitthal Shinde (Director). Past directors included Anjan Choudhury. Its latest AGM occurred on 29 July 2024, with the balance sheet filed on 31 March 2024. It is based at Shop No.103, 2Nd Floor, Plot No.C-39A, Gami Industrial Park, Pawane, Thane, Maharashtra, 400710.
U24290MH2012PTC233594
233594
20 July 2012
₹0.50 M
₹0.50 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Clementia Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Milind S Tawade | Director | 20 Jul 2012 | Current |
| Sudeepto Deepak Nag | Director | 20 Jul 2012 | Current |
| Ganesh Vitthal Shinde | Director | 20 Jul 2012 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 09 Feb 2016 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Clementia Pharmaceuticals Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 17.07% decrease. The company also saw a substantial fall in profitability, with a 30.67% decrease in profit. The company's net worth Soared by an impressive increase of 12.61%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Clementia Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Clementia Pharmaceuticals has a workforce of 19 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Clementia Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Clementia Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Clementia Pharmaceuticals Private Limited last Annual general meeting of members was held on 29 Jul 2024 as per latest MCA records. was documented.
Progress on Clementia Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.
Progress on Milind S Tawade was appointed as a Director was appointed as a Director on 20 Jul 2012 & has been associated with this company since 13 years 5 months . was documented.
Progress on Sudeepto Deepak Nag was appointed as a Director was appointed as a Director on 20 Jul 2012 & has been associated with this company since 13 years 5 months . was documented.
Progress on Ganesh Vitthal Shinde was appointed as a Director was appointed as a Director on 20 Jul 2012 & has been associated with this company since 13 years 5 months . was documented.
The activity Clementia Pharmaceuticals Private Limited was registered on 20 Jul 2012 with Roc Mumbai & aged 13 years 5 months as per MCA records. was completed.
The CIN of Clementia Pharmaceuticals Private Limited is U24290MH2012PTC233594.
Clementia Pharmaceuticals Private Limited is headquartered at Shop No.103, 2Nd Floor, Plot No.C-39A, Gami Industrial Park, Pawane, Thane, Maharashtra, 400710.
Clementia Pharmaceuticals Private Limited was incorporated on 20 July 2012.
The current directors of Clementia Pharmaceuticals Private Limited are
The primary industry of Clementia Pharmaceuticals Private Limited is Trade.
Clementia Pharmaceuticals Private Limited is unlisted.
The authorized capital of Clementia Pharmaceuticals Private Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.
The compliance status of Clementia Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX